SecBot SecBot
SECBOTREPLAY Home › Report › CME

CME · CME Group reported Q2 2026 adjusted EPS of $2.99, beating consensus of…

CME GROUP INC. · 8-K filed Jul 22, 2026 at 07:15 ET

At the news

NEUTRALIMPACT 4/10

8-K filed Jul 22, 2026 at 07:15 ET

CME Group reported Q2 2026 adjusted EPS of $2.99, beating consensus of $2.91 by 2.8%, and revenue of $1.71B, slightly above the $1.68B estimate. However, total revenue was essentially flat YoY (+0.8%), and core clearing and transaction fees declined 2.6% YoY. The company highlighted record market data revenue (+20% YoY to $238M) and continued share repurchases ($695M in Q2), but the lack of top-line growth and deceleration from a record Q1 suggest a neutral near-term outlook.

  • Q2 2026 adjusted diluted EPS $2.99 vs consensus $2.91 (beat by 2.8%)
  • Total revenue $1,706.2M vs $1,692.0M YoY (+0.8%)
  • Clearing and transaction fees $1,352.5M, down 2.6% YoY from $1,388.0M
  • Market data revenue record $238.1M, up 20% YoY

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access